RxDoctor Payments Data

Elizabeth Stoebe, DO

Family Medicine · Fort Dodge, IANPI 1992780365

Payments from drug & device makers

$566in general payments, 2019–2025

Across 24 payments — averaging $23.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$200
  • Dexcom, Inc.$43
  • Johnson & Johnson$39
  • Lilly USA, LLC$36
  • Vanda Pharmaceuticals Inc.$34
  • Takeda Pharmaceuticals U.S.A., Inc.$30
  • plus $184 from 11 others

What the payments were for

  • Food & beverage$38167%
  • Education$18533%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$566 in reported general payments places this provider in the 75th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$2,012
Medicare patients
62
Services billed
163

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$60,571
MounjaroTirzepatide41$46,412
EliquisApixaban44$22,966
Tresiba Flextouch U-200Insulin Degludec19$16,419
Novolog FlexpenInsulin Aspart18$4,377
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$2,729
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$2,414
Gabapentin83$1,658
SavellaMilnacipran Hcl12$1,488
NovologInsulin Aspart13$1,019
Omeprazole121$918
Atorvastatin Calcium133$897
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen50$814
Levothyroxine Sodium115$796
Albuterol Sulfate HfaAlbuterol Sulfate28$737

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$29$61,59068 claims
Lilly USA, LLCMounjaro$36$46,41241 claims
PfizerEliquis$22$22,96644 claims
AbbVieSavella, Synthroid$20$1,90523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Fort Dodge

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →